PHI with Intracranial venous sinus thrombosis

How does this condition affect your private health insurance?

Intracranial Venous Sinus Thrombosis (ICVST) is a rare but serious condition where a blood clot forms in one or more of the brain's venous sinuses, obstructing the drainage of blood. This can lead to increased intracranial pressure, hemorrhage, and brain damage. Symptoms vary widely and may include severe headaches, seizures, focal neurological deficits, altered consciousness, and visual disturbances. Causes are diverse, ranging from genetic thrombophilias and oral contraceptive use to infections, pregnancy, and dehydration. Diagnosis relies on neuroimaging like CT venography or MR venography. Prompt treatment, primarily with anticoagulation, is crucial to prevent further clot propagation and improve outcomes, though residual deficits can occur.

PKV Risk Assessment

Very High Risk of Rejection

Individual, specialized PHI providers may still insure you, but with a significant surcharge.

Impact on Your Insurance Policy

Duration of Illness (Initial)

Several days to several weeks for acute symptoms and initial hospitalization.

Duration of Illness (Lifetime)

Typically a one-time event, but may require prolonged follow-up or long-term anticoagulant therapy for several months to years.

Cost of Treatment (Initial)

USD 20,000 - 80,000 for acute hospitalization, diagnosis, and initial management.

Cost of Treatment (Lifetime)

USD 500 - 5,000 annually for follow-up; significantly more if long-term rehabilitation or chronic medication for complications is required (e.g., USD 10,000 - 50,000+).

Mortality Rate

5-15%, lower with timely diagnosis and treatment.

Risk of Secondary Damages

10-30% for persistent neurological deficits (e.g., weakness, cognitive impairment), chronic headaches, or epilepsy.

Probability of Full Recovery

70-85% for complete or near-complete recovery without significant long-term consequences.

Underlying Disease Risk

High (50-80%) due to associated conditions like inherited or acquired thrombophilia, oral contraceptive use, pregnancy/puerperium, infections, malignancy, or systemic inflammatory diseases.

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.